These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7047791)

  • 41. [Clinical results of cefaclor treatment of infections of oral regions].
    Yoshida Y; Kita T; Kanematsu N; Sato K; Kawata K; Fukuta N; Sato J
    Jpn J Antibiot; 1984 Mar; 37(3):318-28. PubMed ID: 6737694
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of cefaclor.
    Derry JE
    Am J Hosp Pharm; 1981 Jan; 38(1):54-8. PubMed ID: 7011003
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and bacteriological evaluation of cefaclor and tetracycline in acute episodes of bacterial bronchitis.
    Smialowicz CR
    Clin Ther; 1982; 5(2):113-9. PubMed ID: 7159894
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative efficacy of cefadroxil and cefaclor in the treatment of skin and soft-tissue infections.
    Ballantyne FN
    Clin Ther; 1985; 7(4):487-91. PubMed ID: 4016827
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cefaclor in dermatological therapy (author's transl)].
    Paul E
    Infection; 1979; 7 Suppl 6():622-3. PubMed ID: 551090
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of otitis media in children. A comparison between cefaclor and amoxycillin.
    John WR; Vallé-Jones JC
    Practitioner; 1983 Dec; 227(1386):1805-9. PubMed ID: 6361721
    [No Abstract]   [Full Text] [Related]  

  • 47. Comparison of cefaclor and ampicillin in the treatment of shigellosis.
    Ostrower VG
    Postgrad Med J; 1979; 55 Suppl 4():82-4. PubMed ID: 398485
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Fundamental and clinical studies of S 6472 (sustained release preparation of cefaclor) in the pediatric field].
    Sugita M; Toyonaga Y; Nakamura H; Kurosu Y; Hori M
    Jpn J Antibiot; 1985 Sep; 38(9):2444-52. PubMed ID: 3908736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pharmacokinetics of cefaclor and initial therapeutical experience (author's transl)].
    Lode H; Köppe P; Stahlmann R
    Infection; 1979; 7 Suppl 6():600-5. PubMed ID: 551086
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cefaclor--a new oral cephalosporin.
    Drug Ther Bull; 1979 Aug; 17(18):69-70. PubMed ID: 498945
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinical studies on te concentration of cefaclor in sera and lung tissues of patients with respiratory diseases].
    Imaizumi M; Kajita M; Fujita K; Niimi T; Kamiya I; Takahashi T; Asaoka M; Abe T
    Jpn J Antibiot; 1986 Oct; 39(10):2754-60. PubMed ID: 3806958
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical evaluation of cefpodoxime proxetil in the treatment of skin and soft tissue infections. A double blind comparison of cefpodoxime proxetil and cefaclor].
    Yura J; Shinagawa N; Mizuno A; Watanabe S; Ando M; Sakai K; Ueda T; Morimoto K; Nakamura T; Hashimoto I
    Jpn J Antibiot; 1988 Oct; 41(10):1517-37. PubMed ID: 3060626
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Penetration of cefaclor to adenoid tissue and middle ear fluid in secretory otitis media.
    Edén T; Anari M; Ernstson S; Sundberg L
    Scand J Infect Dis Suppl; 1983; 39():48-52. PubMed ID: 6580733
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapy with cefaclor: analysis of infections in 189 French patients.
    Masbernard A; Salord JC
    Postgrad Med J; 1979; 55 Suppl 4():72-6. PubMed ID: 398484
    [No Abstract]   [Full Text] [Related]  

  • 55. [Fundamental and clinical studies on S6472 (a new prolonged acting preparation of cefaclor) in the urological field].
    Kamidono S; Fujii A; Harada M; Arakawa S; Umezu K; Kataoka N; Ishigami J; Hirooka K; Shimatani N; Matsushita M
    Jpn J Antibiot; 1985 Mar; 38(3):869-904. PubMed ID: 3928939
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A double-blind study of cefaclor and amoxycillin in home and hospital-acquired infections.
    Harrower AD
    Curr Med Res Opin; 1982; 8(1):1-4. PubMed ID: 7105818
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A parallel comparative double blind study of cefixime with cefaclor in the treatment of acute suppurative otitis media in children].
    Baba S; Kinoshita H; Mori Y; Suzuki K; Shimada J; Kawamura S; Onishi S; Ueda R; Kobayashi K; Itoh Y
    Jpn J Antibiot; 1987 Jan; 40(1):1-24. PubMed ID: 3295321
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Pharmacological and clinical studies on the long acting cefaclor (S6472)].
    Fujimoto M; Sakai K; Ueda T; Doi S; Sasaki T; Morimoto Y; Sawada A; Masada A
    Jpn J Antibiot; 1985 Mar; 38(3):849-57. PubMed ID: 3897612
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Subinhibitory activity of cefaclor and cephalexin (author's transl)].
    Shah PM; Staszewski S
    Infection; 1979; 7 Suppl 6():543-6. PubMed ID: 399246
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Three-day and seven-day treatment in acute otitis media: a double-blind antibiotic trial.
    Jones R; Bain J
    J R Coll Gen Pract; 1986 Aug; 36(289):356-8. PubMed ID: 3735223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.